Insmed Inc (INSM)

[ED20332]

Insmed: Court decision does not fully resolve all issues

Print | | Disable live quotes By Gabriel Madway
Last Update: 2:33 PM ET Jul 5, 2006


SAN FRANCISCO (MarketWatch) -- Insmed Inc. (INSM : insmed inc com new
News , chart, profile, more
Last: 1.43-0.11-7.14%

2:46pm 07/05/2006

Delayed quote dataAdd to portfolio
Analyst
Create alertInsider
Discuss
Financials
Sponsored by:
INSM1.43, -0.11, -7.1%) said Wednesday that last Friday's court decision does not fully resolve all of the pending issues regarding any of the three patents at issue. Tercica Inc. (TRCA : tercica inc com
News , chart, profile, more
Last: 5.15-0.12-2.28%

2:46pm 07/05/2006


TRCA5.15, -0.12, -2.3%) said earlier Wednesday that the district court ruled that Insmed infringed on three patent claims related to its Iplex compound. Glen Allen, Va.-based Insmed said the remaining issues will be resolved at trial, and that the decision does not have any impact on its ability to continue to sell Iplex, a treatment for children with short stature associated with severe primary IGF-I deficiency.